An Introduction to Influenza
Pre-clinical and clinical studies are identifying new preventive vaccines and antiviral therapies
essential for effectively managing influenza from the population level to the individual patient. Ongoing research is refining demographically targeted
approaches to influenza to optimize antibody response, including high-dose vaccines
for older people, tri- and quadrivalent vaccines to expand protective benefit and
the first approved cell-based vaccine. Data from epidemiological studies are
guiding more effective public health and surveillance strategies to identify and
respond to circulating and novel influenzas.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Christopher Butler, ERS 2020 – Antiviral Therapy for Influenza
We were delighted to speak with Prof. Christopher Butler (University of Oxford, Oxford, UK) about antiviral therapies for influenza and, in particular, the findings from the ALIC4E trial. Questions 1. What are the current recommendations for the use of antiviral therapy for the treatment of influenza? (0:07) 2. Why is oseltamivir not more widely used […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!